CDH-Backed Drug Developer Innorna Is Said to Plan Hong Kong IPO

Innorna Co., a Chinese developer of messenger RNA drugs backed by buyout firm CDH Investments, is planning an initial public offering in Hong Kong, according to people familiar with the matter.

Related Posts:

See also  Australia Explores Copyright Law Changes to Meet AI Challenges